Testing a new gout medicine for people with high uric acid
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new tablet called BR2251 for people with gout and high uric acid. It aims to lower uric acid levels and manage gout symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have gout and a serum uric acid level of 420 μmol/L or higher.
- You must have a body mass index (BMI) between 18 and 35.
- You must not have had a gout flare in the last 2 weeks.
- You must be able to avoid certain medications like aspirin, diuretics, and other gout drugs for at least 2 weeks before the trial.
- You must agree to use effective birth control if you or your partner could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if testing for a specific gene (HLA-B*58:01) before starting gout medication can prevent severe allergic reactions. It compares standard care with a gene-guided approach to see which is safer and works better.
This study tests if a type 2 diabetes medication (SGLT2 inhibitor) can help people with frequent gout flares. It aims to lower uric acid levels and reduce flare-ups.
This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.
This trial tests a new tablet (HR091506) for adults with gout and high uric acid. It aims to lower uric acid levels and reduce gout attacks, especially for people with more severe gout (like tophi or frequent attacks).
This study tests if a new drug, ABP-671, can safely lower high uric acid levels in people with chronic kidney disease. It may help reduce gout attacks and kidney damage.
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
Hear when a new Gout and Hyperuricemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.